Search

everythinglearnresearchcommunity

for

Search:↓

The fuzzy gene is crucial for controlling hair growth cycles.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

IL16 gene variations may affect the risk of alopecia areata in Koreans.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The study found that variations in hair protein genes are likely due to evolutionary deletions or duplications.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Certain variations of the HDAC9 gene can increase or decrease stroke risk in the Chinese population.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Certain genetic changes in the STX17 and KRT82 genes contribute to hair loss in alopecia areata.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

The Eda gene helps regulate the hair cycle in goats.